Instituto Jalisciense de Investigacion Clinica S.A. de C.V.
Guadalajara, Mexico
Medical clinic in Guadalajara
C. Penitenciaría 20, Americana, 44160 Guadalajara, Jal.
About Instituto Jalisciense de Investigacion Clinica S.A. de C.V.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Instituto Jalisciense de Investigacion Clinica S.A. de C.V.
During the past decade, Instituto Jalisciense de Investigacion Clinica S.A. de C.V. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis
2016-10-01
2017-08-01
Completed
74
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
2018-03-07
2019-02-05
Completed
385
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
2018-07-13
2020-09-09
Terminated
484
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
2018-05-01
2018-10-08
Completed
116
A Study Evaluating the Long-term Safety of VX-445 Combination Therapy
2019-08-09
2022-12-14
Completed
458
A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
2019-08-28
2020-06-12
Completed
271
Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy
2019-12-05
2022-12-16
Completed
251
A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)
2021-01-18
2022-07-14
Completed
69
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V."
#1 collaborator was "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Instituto Jalisciense de Investigacion Clinica S.A. de C.V.
According to Clinical.Site data, the most researched conditions in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V." are
"Asthma" (3 trials), "COVID-19" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Chronic Rhinosinusitis" (2 trials) and "Nasal Polyps" (2 trials). Many other conditions were trialed in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V." in a lesser frequency.
Clinical Trials Intervention Types at Instituto Jalisciense de Investigacion Clinica S.A. de C.V.
Most popular intervention types in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V." are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Lebrikizumab" (4 trials), "Omalizumab" (2 trials), "Astegolimab" (1 trials) and "Inhaled mannitol" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto Jalisciense de Investigacion Clinica S.A. de C.V.
The vast majority of trials in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V." are
11 trials for "All" genders.
Clinical Trials Status at Instituto Jalisciense de Investigacion Clinica S.A. de C.V.
Currently, there are NaN active trials in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V.".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Instituto Jalisciense de Investigacion Clinica S.A. de C.V.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Jalisciense de Investigacion Clinica S.A. de C.V., 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".